Related Experiment Video
Updated: May 21, 2025
Vessel-sparing Excision and Primary Anastomosis
Published on: January 7, 2019
Intravesical Botulinum Toxin Injection for Treating Detrusor Overactivity and Poor Compliance in Posterior Urethral
Sharon Mohan Kunnath1, Eskinder Solomon2, Pankaj Mishra1
1Department of Paediatric Urology, Evelina London Children's Hospital, Westminster Bridge Road, London, UK.
Purpose:
To report our preliminary experience on the use of Botulinum toxin A in boys with posterior urethral valves for treating detrusor overactivity and/or reduced bladder compliance not responsive to medical treatment.
Material And Methods:
Primary outcome measures studied were change in baseline end fill pressure (pDet), compliance, maximum Detrusor overactivity pressure (DO), fractional bladder capacity (FBC), vesicoureteric reflux (VUR) grade/resolution. Secondary outcome measures were serum creatinine and estimated glomerular filtration rate (eGFR). Low compliance group was defined as rise in baseline pDet > 20 cmH2O. High pressure DO was defined as maximum pDet > 40 cmH20.
Results:
A total of 15 children were included in the analysis. The median decrease in end fill pDet in the whole cohort was from 20 cmH2O (14.5-30) to 16 cmH2O (10.5-22) (p = 0.065). By analyzing the patients with low compliance, we identified a median decrease in end fill pDet from 32 cmH2O (26.5-44.5) to 19 cmH2O (16.5-25.5) (p = 0.028). The median change in compliance for all the boys was from 6 mL/cmH2O (4.51-7.3) to 12.1 mL/cmH2O (7.44-17.3) (p < 0.001). The median change in compliance in the low compliance group was from 5.5 mL/cmH2O (4.42-7.1) to 8.8 mL/cmH2O (7.39-13.3) (p = 0.018). The median change in fractional bladder capacity for all the boys was from 0.70 (0.55-0.92) to 0.98 (0.79-1.42) (p = 0.061). A complete resolution of DO was observed in 7 out of 11 patients. Complete resolution of VUR was observed in 5 out of 8 renal units.
Conclusion:
Botulinum toxin A can be considered in the treatment strategy for reduced bladder compliance and detrusor overactivity in boys with PUV.
Trial Registration:
15894.
Related Concept Videos
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
01:31Skeletal Muscle Relaxants: Therapeutic Uses
01:26The Micturition Reflex
The process begins with bladder filling, where the bladder wall stretches as urine accumulates. This stretching activates the urine storage reflex, mediated by the sacral spinal segments and the pontine storage center. Efferent sympathetic impulses stimulate the detrusor muscle to relax and the internal urethral sphincter to contract, facilitating...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...